title: Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases.
authors.forename: F
authors.initials: F
authors.lastname: Desta
authors.forename: D H
authors.initials: DH
authors.lastname: Christiansen
authors.forename: M K
authors.initials: MK
authors.lastname: Andersen
authors.forename: J
authors.initials: J
authors.lastname: Pedersen-Bjergaard
mesh_terms: D000208:Acute Disease; D006801:Humans; D053614:Janus Kinase 2; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000201:enzymology / Q000235:genetics*; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000201:enzymology / Q000235:genetics*; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*
chemical_list: D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2